<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03363139</url>
  </required_header>
  <id_info>
    <org_study_id>GECP 17/03_RING</org_study_id>
    <nct_id>NCT03363139</nct_id>
  </id_info>
  <brief_title>T790M Mutation Testing in Blood by Different Methodologies</brief_title>
  <official_title>&quot;T790M Mutation Testing in Blood by Different Methodologies&quot;_RING Project</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spanish Lung Cancer Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Spanish Lung Cancer Group</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Three laboratories will participate in the study. Each laboratory will analyze the same
      samples by different methodologies according to the flow indicated in figure 1. This design
      will allow comparing the agreement performance of different methods available for T790M
      identification in circulating-free DNA isolated from peripheral blood.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Three blood samples per patient will be collected once at the time of progression, assessed
      by CT Scans according to RECIST criteria v.1.1 and before the patients start a new treatment
      The blood samples (5-10 mL each) will be collected in one Cell-Free DNA BCT Streck® and 2 PTT
      EDTA K2 (BECTON DICKINSON) collection tubes.

      All samples will be labeled properly with the patient identification number and date of
      extraction. These samples will be stored and distributed through the 3 participating
      laboratories until completion of all the analyses, according to the flowchart in Figure 1.
      These samples will be registered in the samples collection of the Institute of Health Carlos
      III Registry. These samples will be kept in each participant laboratory after the completion
      of the RING study and the patient will be informed of that in the patient information sheet
      and informed consent.

      cfDNA will be extracted using as starting volume 1 ml of plasma with a Maxwell® RSC
      instrument (Promega), using the Maxwell® RSC cfDNA Plasma Kit (MR), as specified by the
      manufacturer or with a Qiasymphony instrument (Qiagen company). Additionally, for BEAMing
      analysis, 3 ml of plasma will be used for cfDNA isolation using the the QIAamp® Circulating
      Nucleic Acid Kit (Qiagen company), following the manufacturer instructions.

      Circulating free DNA from peripheral blood sample is an adequate source for T790M resistance
      mutation testing. However, comparison across different platforms has been scarcely reported.
      Discordant results for EGFR biomarker testing could impact patient management.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2018</start_date>
  <completion_date type="Anticipated">September 15, 2019</completion_date>
  <primary_completion_date type="Anticipated">January 15, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Assess the agreement between qualitative methodologies</measure>
    <time_frame>At 12 months from the first inclusion</time_frame>
    <description>To evaluate the agreement performance of different methodologies available in Spain for T790M identification in circulating-free DNA isolated from blood collected at the time of progression on a first or second generation TKI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cost of the different methodologies</measure>
    <time_frame>At 12 months from the first inclusion</time_frame>
    <description>To compare the cost of the different methodologies</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specificity and sensitivity of each cfDNA method</measure>
    <time_frame>At 12 months from the first inclusion</time_frame>
    <description>To estimate the specificity and sensitivity of each cfDNA method.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Turnaround time of different methodologies</measure>
    <time_frame>At 12 months from the first inclusion</time_frame>
    <description>To compare turnaround time of the different methodologies</description>
  </other_outcome>
  <other_outcome>
    <measure>Ease of use of different methodologies</measure>
    <time_frame>At 12 months from the first inclusion</time_frame>
    <description>To compare the ease of use of the different methodologies</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">72</enrollment>
  <condition>NSCLC Stage IV</condition>
  <arm_group>
    <arm_group_label>Patients with T790M mutation</arm_group_label>
    <description>Patient who has progressed to Tyrosin Kinase inhibitors and has the mutation of the gen T790M</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tirosin Kinase Inhibitors</intervention_name>
    <description>Patients that received Tyrosin Kinase inhibitors and progressed</description>
    <arm_group_label>Patients with T790M mutation</arm_group_label>
    <other_name>TKI</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples in a EDTA tube will be drawn to extract DNA and analyse T790M mutation in NSCLC
      patients
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        EGFR mutant non small cell lung cancer patients.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients diagnosed with EGFR mutant, stage IIIB and IV non small cell lung cancer and
             who have progressed assessed by CT Scans according to RECIST criteria v.1.1 to first
             or second generation EGFR tyrosine kinase inhibitors (TKIs) (e.g. gefitinib,
             erlotinib, afatinib) including patients who received a chemotherapy line before TKI
             treatment. Samples have to be drawn before the patient starts a new treatment,

          -  Patients have to sign the informed consent of the study

          -  Patients aged ≥ 18 years.

        Exclusion Criteria:

          -  Patients progressing to third generation EGFR TKIs (e.g. Osimertinib (TKI))

          -  No possibility of venipuncture.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mariano Provencio, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Puerta del Hierro</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mariano Provencio, PhD</last_name>
    <phone>+ 34 93 430 20 06</phone>
    <email>gecp@gecp.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eva Pereira</last_name>
    <phone>+ 34 93 430 20 06</phone>
    <email>epereira@gecp.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Complejo Hospitalario Universitario de Santiago</name>
      <address>
        <city>Santiago De Compostela</city>
        <state>A Coruña</state>
        <zip>15706</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jorge García, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jorge García, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de los Lirios</name>
      <address>
        <city>Alcoy</city>
        <state>Alicante</state>
        <zip>03804</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Javier Pérez, MD</last_name>
    </contact>
    <investigator>
      <last_name>Javier Pérez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario de Elche</name>
      <address>
        <city>Elche</city>
        <state>Alicante</state>
        <zip>03203</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>María Guirado, MD</last_name>
    </contact>
    <investigator>
      <last_name>María Guirado, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Central de Asturias</name>
      <address>
        <city>Oviedo</city>
        <state>Asturias</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Noemí Villanueva, MD</last_name>
    </contact>
    <investigator>
      <last_name>Noemí Villanueva, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Universitario Insular de Gran Canaria</name>
      <address>
        <city>Las Palmas de Gran Canaria</city>
        <state>Gran Canaria</state>
        <zip>35016</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gretel Benítez, MD</last_name>
    </contact>
    <investigator>
      <last_name>Gretel Benítez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Príncipe de Asturias</name>
      <address>
        <city>Alcalá De Henares</city>
        <state>Madrid</state>
        <zip>28805</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fátima Navarro, MD</last_name>
    </contact>
    <investigator>
      <last_name>Fátima Navarro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Severo Ochoa</name>
      <address>
        <city>Leganés</city>
        <state>Madrid</state>
        <zip>28911</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Ana López, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>H. Son Espases</name>
      <address>
        <city>Palma de Mallorca</city>
        <state>Mallorca</state>
        <zip>07014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Raquel Marsé, MD</last_name>
      <phone>+34971175000</phone>
      <phone_ext>76130</phone_ext>
    </contact>
    <investigator>
      <last_name>Raquel Marsé, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario de Navarra</name>
      <address>
        <city>Pamplona</city>
        <state>Navarra</state>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Berta Hernández, MD</last_name>
    </contact>
    <investigator>
      <last_name>Berta Hernández, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>H. Gen. Universitario de Alicante</name>
      <address>
        <city>Alicante</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bartomeu Massutí, MD</last_name>
    </contact>
    <investigator>
      <last_name>Bartomeu Massutí, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Instituto Universitario Dexeus</name>
      <address>
        <city>Barcelona</city>
        <zip>08028</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Santiago Viteri, MD</last_name>
      <phone>+34935460143</phone>
    </contact>
    <investigator>
      <last_name>Santiago Viteri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de La Santa Creu I Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Margarita Majem, MD-PhD</last_name>
    </contact>
    <investigator>
      <last_name>Margarita Majem</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Burgos</name>
      <address>
        <city>Burgos</city>
        <zip>09006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carlos García, MD</last_name>
    </contact>
    <investigator>
      <last_name>Carlos García, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Ciudad Real</name>
      <address>
        <city>Ciudad Real</city>
        <zip>13005</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>José Carlos Villa, MD</last_name>
    </contact>
    <investigator>
      <last_name>José Carlos Villa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ICO Girona -H. Dr. Josep Trueta</name>
      <address>
        <city>Girona</city>
        <zip>17007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joaquim Bosch, MD</last_name>
      <phone>+34972225828</phone>
    </contact>
    <investigator>
      <last_name>Joaquim Bosch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico San Cecilio</name>
      <address>
        <city>Granada</city>
        <zip>18012</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>José Miguel Jurado, MD</last_name>
    </contact>
    <investigator>
      <last_name>José Miguel Jurado, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario de Jaén</name>
      <address>
        <city>Jaén</city>
        <zip>23007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ana Laura Ortega, MD</last_name>
    </contact>
    <investigator>
      <last_name>Ana Laura Ortega, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Asistencial Universitario de León</name>
      <address>
        <city>León</city>
        <zip>24071</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pilar Diz, MD</last_name>
    </contact>
    <investigator>
      <last_name>Pilar Diz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Lucus Agustí</name>
      <address>
        <city>Lugo</city>
        <zip>27003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Begoña Campos, MD</last_name>
      <phone>+34 982296000</phone>
      <email>begona.campo.balea2@sergas.es</email>
    </contact>
    <investigator>
      <last_name>Begoña Campos</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>H.U. Puerta de Hierro</name>
      <address>
        <city>Madrid</city>
        <zip>28035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mariano Provencio, MD</last_name>
      <phone>+34913445131</phone>
      <email>mprovenciop@seom.org</email>
    </contact>
    <investigator>
      <last_name>Mariano Provencio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patricia Cruz, MD</last_name>
    </contact>
    <investigator>
      <last_name>Patricia Cruz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Sanchinarro</name>
      <address>
        <city>Madrid</city>
        <zip>28050</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ana Collazo, MD</last_name>
    </contact>
    <investigator>
      <last_name>Ana Collazo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario Virgen de la Arrixaca</name>
      <address>
        <city>Murcia</city>
        <zip>30120</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Juana Campillo, MD</last_name>
    </contact>
    <investigator>
      <last_name>Juana Campillo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>H. Carlos Haya</name>
      <address>
        <city>Málaga</city>
        <zip>29010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Manuel Cobo, MD</last_name>
      <phone>+34951290000</phone>
    </contact>
    <investigator>
      <last_name>Manuel Cobo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen del Rocío</name>
      <address>
        <city>Sevilla</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Reyes Bernabé, MD</last_name>
    </contact>
    <contact_backup>
      <email>epereira@gecp.org</email>
    </contact_backup>
    <investigator>
      <last_name>Reyes Bernabé, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Amelia Insa, MD</last_name>
    </contact>
    <investigator>
      <last_name>Amelia Insa</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital La Fe</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Óscar Juan, MD</last_name>
    </contact>
    <investigator>
      <last_name>Óscar Juan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>H. Gen. Univ. Valencia</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carlos Camps, MD</last_name>
    </contact>
    <investigator>
      <last_name>Carlos Camps, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Arnau de Vilanova</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Javier Garde</last_name>
    </contact>
    <investigator>
      <last_name>Javier Garde</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Nuestra Señora de Sonsoles</name>
      <address>
        <city>Ávila</city>
        <zip>05004</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rosa Ana Marcos, MD</last_name>
    </contact>
    <investigator>
      <last_name>Rosa Ana Marcos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>http://www.gecp.org</url>
    <description>Grupo Español de Cáncer de Pulmón</description>
  </link>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2017</study_first_submitted>
  <study_first_submitted_qc>November 29, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 6, 2017</study_first_posted>
  <last_update_submitted>April 23, 2018</last_update_submitted>
  <last_update_submitted_qc>April 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

